Allscripts reinvigorating its EPSi™ business to accelerate innovation, drive client success
June 27 2016 - 8:01AM
Allscripts (NASDAQ:MDRX) has implemented an aggressive strategy to
drive innovation and client success through the EPSi solution, its
flagship budgeting, cost accounting and financial decision support
platform. The company will accelerate development with new
executive leadership and a future-focused roadmap to meet rapidly
changing market needs.
“Having been a chief financial officer myself, I
understand the strategic importance of tools like EPSi for
financial planning, scenario modeling and critical decision support
in a time of rapid industry transition,” Allscripts President Rick
Poulton said. “We’re executing our plan by making a significant
investment in EPSi to further advance its place as a market-leading
solution.”
As of June 27, EPSi founder Tim Rutledge and former management
executives Ralph Keiser and John Gragg will join Allscripts to lead
the efforts in executing the new solution strategy. Ralph Keiser
will be the CEO of the EPSi business unit, with John Gragg
functioning as COO and Tim Rutledge as Chief Product Architect.
Chuck Manternach, who has been with Allscripts since 2005, will
also take on a greater leadership role in the organization as
Associate General Manager for EPSi. With extensive industry
experience and knowledge, this team will develop a new product
roadmap that will keep EPSi users at the forefront of healthcare
evolution.
In conjunction with the investment in EPSi, Allscripts has
acquired RealCost.io, Inc., a next-generation decision support and
analytics firm founded by Keiser, Rutledge and Gragg.
“We are excited to join Allscripts and lead the
EPSi business into its next phase of growth and innovation,” said
Keiser. “Our focus will be to improve the current client experience
with our products and services and to expand the capabilities of
our market-leading platform that powers some of the largest
healthcare systems in the market. I look forward to working with
the EPSi team to create and launch innovative solutions that help
our clients as they transition from volume to value and deliver
cost saving operational efficiencies.”
“These industry leaders had the vision to create
EPSi, and now they will use their expertise to advance the solution
to the next level,” Poulton said. “We remain 100% committed to our
long-term partnership with clients and delivering the best EPSi
solutions.”
About AllscriptsAllscripts
(NASDAQ:MDRX) is a leader in healthcare information technology
solutions that advance clinical, financial and operational results.
Our innovative solutions connect people, places and data across an
Open, Connected Community of Health™. Connectivity empowers
caregivers to make better decisions and deliver better care for
healthier populations. To learn more, visit
www.allscripts.com, Twitter, YouTube and
It Takes A Community: The Allscripts Blog.
© 2016 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other
Allscripts marks are trademarks of Allscripts Healthcare, LLC
and/or its affiliates. All other products are trademarks of their
respective holders, all rights reserved. Reference to these
products is not intended to imply affiliation with or sponsorship
of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Seth Frank
312-506-1213
seth.frank@allscripts.com
Media:
Concetta DiFranco
312-447-2466
concetta.difranco@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024